Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents
Acta Dermato-Venereologica, 10/29/09
Matusiak T et al. – Hidradenitis suppurativa (HS) is a recurrent, debilitating suppurative skin disease. Nowadays the major challenge is the choice of optimal treatment. Many conservative therapies seem to have only a supportive character and do not prevent progression of the disease. Early surgical intervention with complete excision of the involved areas is still considered to be the most efficient therapy, but anti–tumour necrosis factor (TNF)– agents may offer a possible non–surgical treatment.
Related Articles
Idiopathic pustular vulvitis
Clinical and Experimental Dermatology, 10/07/09
Relevance Score: 80%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Persistent plaque with severe intermittent pruritus
The Clinical Advisor, 12/18/09
Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas
Journal of the European Academy of Dermatology and Venereology, 12/18/09
Surgical treatment of sacrococcygeal pilonidal sinus with rhomboid flap
Journal of the European Academy of Dermatology and Venereology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


